Fibrin Binding of Plasminogen Coated Liposomes In Vitro

Summary

In this study, the fibrin binding properties of liposomes containing a number of plasminogen (Pig) molecules on the outside were compared to those of free (non-liposomal) Pig in an in vitro model system. Fibrin monolayer coated 96-wells plates were used, containing fibrin monomer at a density of around 3.4 to 3.9 × 10^-4 nmol/cm². These densities are similar to liposomal Plg-densities, thus allowing multivalent interactions to occur.

In the panel of experimental conditions that was chosen, binding of free Pig and liposomes with Pig showed three main differences in characteristics. Firstly, in the fibrin binding of Plg-liposomes not all Pig may be involved, but on the average 40% of the total amount of liposomal Pig. This was shown by lysing the liposomes after binding to the fibrin and estimation of truly bound Pig. With Plg-densities on the liposomes below the fibrin binding sites density, the maximal number of bound Pig molecules remains below the amount of available fibrin binding sites. Secondly, a higher binding rate by at least one order of magnitude was observed for liposomes with Pig compared to free Pig. Thirdly, liposomes with Pig exhibit a fibrin binding affinity which increases with Plg-density, because of the multivalent character of interaction. Liposomal Pig can successfully compete for fibrin binding sites with a 100 fold higher concentration of free Pig.

These in vitro findings indicate that in view of avid and rapid fibrin binding, liposomes with attached plasminogen may be suitable for in vivo targeting to fibrin based thrombi.

• References

• 1 Crommelin DJA, Storm G. Drug targeting. In: Comprehensive Medicinal Chemistry Hansch C, Sammes PG, Taylor JB. eds Pergamon Press pic; Oxford: 1990. 5 661-701
• 2 Crommelin DJA, Schreier H. Liposomes. In: Colloidal drug delivery systems Kreuter J. ed Marcel Dekker Inc; New York: 1994: 073-190
• 3 Vingerhoeds MH, Storm G, Crommelin DJA. Immunoliposomes in vivo. Immunomethods 1994; 4: 259-272
• 4 Heeremans JLM, Kraaijenga JJ, Los P, Kluft C, Crommelin DJA. Development of a procedure for coupling the homing device glu-plasminogen to liposomes. Biochim Biophys Acta 1992; 1117: 258-264
• 5 Duncan RJS, Weston PD, Wrigglesworth R. A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay. Anal Biochem 1983; 132: 68-73
• 6 Heeremans JLM, Prevost R, Bekkers MEA, Los P, Emeis JJ, Kluft C, Crommelin DJA. Thrombolytic treatment with tissue-type Plasminogen Activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA. Thromb Haemost 1995; 73 (03) 488-494
• 7 Martin FJ, Papahadjopoulos D. Irreversible coupling of immuno-globulin fragments to preformed vesicles. J Biol Chem 1982; 257 (01) 286-288
• 8 Ruyven-Vermeer IAM, Nieuwenhuizen W. Purification of rat fibrinogen and its constituent chains. Biochem J 1978; 169: 653-658
• 9 Heeremans JLM, Prevost R, Bischot L, Los P, Kluft C, Crommelin DJA. Interference of e-aminocaproic acid with [N-succinimidyl S-acethylacetate derived] thiol introduction into glu-plasminogen. Fibrinolysis 1994; 8 (Suppl.) (Suppl. 02) 138-141
• 10 Ellman GL. Tissue Sulfhydryl Groups. Arch Biochem Biophys 1959; 82: 70-77
• 11 Bangham AD, Standish MM, Warkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13: 238-252
• 12 Friberger P, Knos M, Gustavsson S, Aurell L, Claeson G. Methods for the determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis 1978; 7: 138-145
• 13 Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble choloroamide, 1,3,4,6,-tetrachloro-3a, 6a-diphenylgly-coluril. Biochem Biophys Res Comm 1978; 80: 849-857
• 14 Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs 1985; 29: 236-261
• 15 Thorsen S. The mechanism of plasminogen activation and the variability of the fibrin effector during tissue-type plasminogen activator-mediated fibrinolysis. Ann NY Acid Sci 1992; 667: 52-63
• 16 Weisel JW, Nagaswami C, Korsholm B, Petersen LC, Suenson E. Interactions of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy. J Mol Biol 1994; 235: 1117-1135
• 17 Suenson E, Thorson S. Secondary-site binding of glu-plasmin, lys-plasmin and miniplasmin to fibrin. Biochem J 1981; 197: 619-628
• 18 Bell GI. Physical chemical aspects of cell surface events in cellular regulation. Delisi C, Blumenthal R. eds Elsevier, North-Holland; New York: 1979
• 19 Ho RJY, Rouse BT, Huang L. Target-sensitive immunoliposomes: preparation and characterization. Biochem 1986; 25: 5500-5506
• 20 Ho RJY, Rouse BT, Huang L. Target-sensitive immunoliposomes as an efficient drug carrier for antiviral activity. J Biol Chem 1987; 262 (29) 13973-13978
• 21 Fleury V, Anglès-Cano E. Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines. Biochem 1991; 30 (30) 7630-7638
• 22 Heath TD, Fraley RT, Bentz J, Voss Jr EW, Herron JN, Papahadjopoulos D. Antibody-directed liposomes. Determination of affinity constants for soluble and liposome-bound antifluorescein. Biochim Biophys Acta 1984; 770: 148-158
• 23 Jones MA, Singh A, Kilpatrick PK, Carbonell RG. Preparation and characterization of ligand-modified labelled liposomes for solid phase immunoassays. J Lipos Res 1993; 3 (03) 793-804
• 24 Plant AL, Gray M, Locascio-Brown L, Yap WT. Hydrodynamics of liposomes and their multivalent interactions with surface receptors. In: Liposome Technology, liposome preparation and related techniques Gregoriadis G. ed CRC Press; 1993. 2nd edition 01 440-453